2024 Global Toxoplasmosis Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

2024 Global Toxoplasmosis Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

  • September 2020 •
  • 226 pages •
  • Report ID: 5841890 •
  • Format: PDF
2024 Global Toxoplasmosis Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed.

The report is available by section, and can be customized to specific information needs and budget.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Toxoplasmosis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

List of Tables

Major Companies Developing or Marketing Toxoplasmosis Tests

France
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
By Market Segment

France
Toxoplasmosis Testing Market Diagnostics Sales
By Major Supplier

Germany
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
By Market Segment

Germany
Toxoplasmosis Testing Market Diagnostics Sales
By Major Supplier

Italy
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
By Market Segment

Italy
Toxoplasmosis Testing Market Diagnostics Sales
By Major Supplier

Japan
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
By Market Segment

Japan
Toxoplasmosis Testing Market Diagnostics Sales
By Major Supplier

Spain
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
by Market Segment

Spain
Toxoplasmosis Testing Market Diagnostics Sales
By Major Supplier

U.K.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
By Market Segment

U.K.
Toxoplasmosis Testing Market Diagnostics Sales
By Major Supplier

U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
By Market Segment

U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales
by Major Supplier

Contains 226 pages and 15 tables



Companies Profiled

Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako